GlassScriptPhysician profile
Michael L Bruck
NPI 1033189055
$1,410.90
in general payments reported to CMS, 2019-2025
19 companies · $334 in 2025
The $334 reported for 2025 was more than what 87% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2020: $65.72 · 2021: $194 · 2022: $181 · 2023: $225 · 2024: $267 · 2025: $334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $825.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $825.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $328.66 | 2022-2025 | Azstarys |
| Pfizer INC. | $164.28 | 2019-2025 | |
| Ironshore Pharmaceuticals INC. | $106.51 | 2019-2024 | |
| Collegium Pharmaceutical, INC. | $101.92 | 2025 | Jornay Pm |
| Sanofi Pasteur INC. | $86.15 | 2021-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $81.20 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $70.16 | 2019-2022 | |
| Tris Pharma INC | $67.63 | 2019-2022 | |
| Tepha INC | $63.35 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $61.75 | 2025 | |
| Adlon Therapeutics L.P. | $61.40 | 2020-2021 | |
| Seqirus USA INC | $52.27 | 2024-2025 | Flucelvax |
| Cranial Technologies, INC | $47.49 | 2019-2022 | |
| Aquestive Therapeutics, INC. | $24.98 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $24.50 | 2024 | Flumist Quadrivalent |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $22.83 | 2025 | Bexsero |
| Supernus Pharmaceuticals, INC. | $16.26 | 2023 | Qelbree |
| Abbvie INC. | $15.56 | 2020 | |
| Vertical Pharmaceuticals, LLC | $14.00 | 2024 | Relexxii |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bruck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.